William Fox, OD
Optometrist · Greensboro, NCNPI 1124086319
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.2%), travel and lodging and entertainment — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Coopervision Inc. at 57.6% of the total. Reporting peaked in 2022 at $5,542 and has fallen 81.3% since, to $1,037 in 2025. Among optometrist clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 165 payments — averaging $115.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$11K
- Alcon$4K
- Johnson & Johnson Vision Care, Inc.$2K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$1K
- Bausch & Lomb Americas Inc.$1K
- Optos, Inc.$87
- plus $153 from 3 others
Across 1 payment — averaging $1345.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Topcon Healthcare, Inc.$1K
What the payments were for
- Travel & lodging$9,00047%
- Food & beverage$9,95552%
- Gifts$190%
- Entertainment$870%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 64 | $10,975 |
| Alcon | 31 | $3,717 |
| Johnson & Johnson Vision Care, Inc. | 34 | $1,671 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 14 | $1,257 |
| Bausch & Lomb Americas Inc. | 16 | $1,202 |
| Optos, Inc. | 2 | $87 |
| Sun Pharmaceutical Industries Inc. | 1 | $74 |
| ABB Con-cise Optical Group LLC | 2 | $59 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Multiple Brands Contact Lens$4,649
- CVI Contact Lens$3,198
- Acuvue$972
- INFUSE$968
- DAILIES$746
- ULTRA$470
- BIOTRUE ONE DAY$465
- Precision7$163
- MyDay Contact Lens$126
- BTOD$125
- Clariti Contact Lens$121
- Rocklatan$111
- Rhopressa$111
How this compares
$19,061 in reported general payments places this provider in the 95th percentile of 1,326 optometrist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 14 | $137 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Greensboro
- Timothy KoopGreensboro$10K
- Heather OmanGreensboro$9K
- Crystal BrimerWilmington$920K
- Osama SaidRaleigh$597K
- Ryan CorteAsheville$569K
- Sanjay PatelApex$518K
- Sean SmolenyakRaleigh$512K
- Rachael WrubleBelmont$228K
- Lisa GreeneArden$186K
- Jennifer LyerlyMorrisville$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.